Skip to main content

MoneyWorks4Me

Aurobindo Pharma informs about press release

07 Jun 2022 Evaluate

Aurobindo Pharma has informed that it enclosed a copy of the Press Release that is being issued by the Company in connection with USFDA approval received by Eugia Pharma Specialities, a wholly owned subsidiary of the Company, for Leuprolide Acetate Injection.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1797.20
Dr. Reddys Labs. 1352.55
Cipla 1373.70
Lupin 2010.00
Zydus Lifesciences 1238.25
View more..